Wear it pink on 24 October This October, wear pink and raise money to help fund life-changing breast cancer research and support.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 204 results We welcome NICE approval of pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) for routine use on the NHS 25 May 2022 2 min read We comment on saliva samples used to determine breast cancer risk in women of screening age 23 May 2022 1 min read We support latest Emmerdale storyline on Faith Dingle's Secondary Breast Cancer diagnosis 17 May 2022 1 min read We respond to new research into how salt in tumours could help diagnose and treat breast cancer 25 Apr 2022 1 min read We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read We respond to research about artificial sweeteners and breast cancer risk 24 Mar 2022 1 min read We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read We respond to NHS England breast cancer waiting times: January 2022 10 Mar 2022 1 min read We respond to NHS England's proposed new standards 09 Mar 2022 1 min read Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read Breast Cancer Now welcomes SMC decision to recommend Trodelvy for use on the NHS in Scotland 07 Mar 2022 3 min read We respond to NICE decision to recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 25 Feb 2022 2 min read Previous 1 ... 11 ... 17 Next
We welcome NICE approval of pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) for routine use on the NHS 25 May 2022 2 min read
We comment on saliva samples used to determine breast cancer risk in women of screening age 23 May 2022 1 min read
We support latest Emmerdale storyline on Faith Dingle's Secondary Breast Cancer diagnosis 17 May 2022 1 min read
We respond to new research into how salt in tumours could help diagnose and treat breast cancer 25 Apr 2022 1 min read
We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read
We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read
Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read
Breast Cancer Now welcomes SMC decision to recommend Trodelvy for use on the NHS in Scotland 07 Mar 2022 3 min read
We respond to NICE decision to recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 25 Feb 2022 2 min read
